Showing results (21-30 of 210) with videos related to
Sort By:
Pageof 21
Progress in Cardiovascular Diseases|January 10, 2012
Approaches to data analyses of clinical trialsCurt D Furberg, Lawrence M FriedmanCurrent Hypertension Reports|November 30, 2014
Plasma renin testing to guide antihypertensive therapyAnthony J Viera, Curt D FurbergJAMA Internal Medicine|October 30, 2013
Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008Thomas J Moore, Curt D FurbergMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 29, 2003
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose toleranceHelmut Sinzinger, Harald Kritz, Curt D FurbergCurrent Opinion in Lipidology|November 13, 2007
Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndromeAllan D Sniderman, May FarajCurrent Opinion in Endocrinology, Diabetes, and Obesity|November 24, 2020
Apolipoprotein B: the Rosetta Stone of lipidologyTamara Glavinovic, Allan D SnidermanBMC Medicine|March 2, 2013
Do statins lower testosterone and does it matter?Allan D Sniderman, George ThanassoulisCurrent Opinion in Cardiology|November 7, 2023
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular careSelin Bilgic, Allan D SnidermanJAMA|September 13, 2007
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysisSonal Singh, Yoon K Loke, Curt D FurbergPlos One|December 24, 2010
Prescription drugs associated with reports of violence towards othersThomas J Moore, Joseph Glenmullen, Curt D FurbergPageof 21